journal
Journals Journal of Prevention of Alzhe...

Journal of Prevention of Alzheimer's Disease

https://read.qxmd.com/read/38374760/letter-to-the-editor-chronic-pain-in-multiple-sites-and-dementia-a-vicious-cycle
#1
JOURNAL ARTICLE
J Tian, G Jones, X Lin, Y Zhou, A King, J Vickers, F Pan
No abstract text is available yet for this article.
2024: Journal of Prevention of Alzheimer's Disease
https://read.qxmd.com/read/38374759/letter-to-the-editor-alzheimer-s-disease-associated-apoe-%C3%AE%C2%B54-frequencies-in-indian-population-genomes-may-suggest-implications-in-lecanemab-treatment
#2
JOURNAL ARTICLE
B Jolly, V Scaria
No abstract text is available yet for this article.
2024: Journal of Prevention of Alzheimer's Disease
https://read.qxmd.com/read/38374758/unsupervised-online-paired-associates-learning-task-from-the-cambridge-neuropsychological-test-automated-battery-cantab%C3%A2-in-the-brain-health-registry
#3
JOURNAL ARTICLE
M T Ashford, A Aaronson, W Kwang, J Eichenbaum, S Gummadi, C Jin, N Cashdollar, E Thorp, E Wragg, K H Zavitz, F Cormack, T Banh, J M Neuhaus, A Ulbricht, M R Camacho, J Fockler, D Flenniken, D Truran, R S Mackin, M W Weiner, R L Nosheny
BACKGROUND: Unsupervised online cognitive assessments have demonstrated promise as an efficient and scalable approach for evaluating cognition in aging, and Alzheimer's disease and related dementias. OBJECTIVES: The aim of this study was to evaluate the feasibility, usability, and construct validity of the Paired Associates Learning task from the Cambridge Neuropsychological Test Automated Battery® in adults enrolled in the Brain Health Registry. DESIGN, SETTING, PARTICIPANTS, MEASUREMENTS: The Paired Associates Learning task was administered to Brain Health Registry participants in a remote, unsupervised, online setting...
2024: Journal of Prevention of Alzheimer's Disease
https://read.qxmd.com/read/38374757/the-impact-of-testosterone-on-alzheimer-s-disease-are-mediated-by-lipid-metabolism-and-obesity-a-mendelian-randomization-study
#4
JOURNAL ARTICLE
L Zhang, F Yang, J Ma, Y Hu, M Li, C Wang, X Chang, L Yang
BACKGROUND: To investigate the causal relationship between testosterone (BT) levels and Alzheimer's disease (AD) risk and to quantify the role of obesity and lipid metabolism as potential mediators. METHODS: We used a two-sample, two-step MR to determine:1) the causal effect of BT levels on AD; 2) the causal effect of two lipid metabolites, obesity and LDLc on AD; and 3) the mediating effects of these metabolites. Pooled data for BT levels and lipid metabolism were obtained from the UK Biobank...
2024: Journal of Prevention of Alzheimer's Disease
https://read.qxmd.com/read/38374756/integrated-bioinformatic-analysis-and-validation-identifies-immune-microenvironment-related-potential-biomarkers-in-alzheimer-s-disease
#5
JOURNAL ARTICLE
F Yang, N Zhang, G-Y Ou, S-W Xu
BACKGROUND: Alzheimer's disease (AD) is one of the most common neurodegenerative diseases, accompanied by cognitive and memory impairment, accounting for about 60% - 80% of dementia types. The pathogenesis of AD has not been clarified, and there is no effective therapy to prevent or treat AD. In this study, we aimed to identify the potential biomarkers involved in the brain immune microenvironment in AD. METHODS: AD datasets from GEO database were obtained to identify the differentially expressed disease-related genes (DEDRGs) in AD through weighted gene co-expression network analysis (WGCNA) and differential expression analysis...
2024: Journal of Prevention of Alzheimer's Disease
https://read.qxmd.com/read/38374755/higher-cognitive-reserve-is-beneficial-for-cognitive-performance-via-various-locus-coeruleus-functional-pathways-in-the-pre-dementia-stage-of-alzheimer-s-disease
#6
JOURNAL ARTICLE
L Gong, K Chen, H Zhang, S Zhang, W Luo, W Zhou, B Zhang, R Xu, C Xi
BACKGROUND: Cognitive reserve (CR) shows protective effects on cognitive function in older adult and in Alzheimer's disease (AD). However, the brain mechanisms underlying the CR effect on the non-dementia AD spectrum (subjective cognitive decline (SCD) and mild cognitive impairment (MCI)) are unknown. The aim of this study was to investigate the potential moderate effect of CR on brain functional networks associated with cognitive performance. METHODS: We selected 200 participants, including 48 cognitively normal (CN) and 56 SCD, and 96 patients with MCI from the Alzheimer's Disease Neuroimaging Initiative (ADNI)...
2024: Journal of Prevention of Alzheimer's Disease
https://read.qxmd.com/read/38374754/beyond-vision-a-view-from-eye-to-alzheimer-s-disease-and-dementia
#7
REVIEW
C Zheng, R Zeng, G Wu, Y Hu, H Yu
With the aging of the global population, the health care burden of Alzheimer's disease (AD) and dementia is considered to increase dramatically in the coming decades. Given the insufficiency of effective interventions for AD and dementia, clinical research on identifying potentially modifiable risk factors and early diagnostic biomarkers becomes a public health priority. Currently, extracerebral manifestations with a large proportion of ocular involvement are usually recognized to precede the symptoms of AD and dementia...
2024: Journal of Prevention of Alzheimer's Disease
https://read.qxmd.com/read/38374753/the-mapp-room-memory-test-examining-contextual-memory-using-a-novel-computerized-test-in-cognitively-unimpaired-individuals-with-autosomal-dominant-alzheimer-s-disease
#8
JOURNAL ARTICLE
A Giudicessi, P A Aduen, J T Fox-Fuller, J E Martinez, L A Gonzalez, C Vila-Castelar, A Baena, C Pluim McDowell, A Cronin-Golomb, F Lopera, Y T Quiroz
Contextual memory, the ability to remember spatial or temporal features related to an event, is affected in Alzheimer's disease (AD). There is a shortfall of tests that measure contextual memory. To evaluate visuospatial contextual memory, we developed a computerized cognitive test, the MAPP Room Memory Test, which requires participants to identify in which visual scene target items were previously presented. We hypothesized that cognitively-unimpaired carriers of an autosomal dominant AD mutation (Presenilin-1 E280A, n=15) would perform more poorly on this test than non-carrier family members (n=31)...
2024: Journal of Prevention of Alzheimer's Disease
https://read.qxmd.com/read/38374752/cardiovascular-risk-scales-association-with-cerebrospinal-fluid-alzheimer-s-disease-biomarkers-in-cardiovascular-low-cardiovascular-risk-regions
#9
JOURNAL ARTICLE
G García-Lluch, J Pardo, L Moreno, C Peña-Bautista, M Baquero, C Cháfer-Pericás
BACKGROUND: Cardiovascular risk factors are associated with Alzheimer's Disease (AD) development. However, few studies compare the overall cardiovascular risk with AD biomarkers, and when done, they are mainly performed in moderate cardiovascular risk regions. OBJECTIVES: To determine whether cardiovascular risk in older adults is associated with pathological cerebrospinal fluid (CSF) biomarkers of AD in a low cardiovascular risk population. DESIGN: This is a cross-sectional study performed between 2017 and 2020...
2024: Journal of Prevention of Alzheimer's Disease
https://read.qxmd.com/read/38374751/fruit-intake-and-alzheimer-s-disease-results-from-mendelian-randomization
#10
JOURNAL ARTICLE
W-Z Liao, X-F Zhu, Q Xin, Y-T Mo, L-L Wang, X-P He, X-G Guo
Alzheimer's disease (AD) is the leading cause of dementia in old age, recognized as a global health priority. To explore causal effects of fresh fruit intake and dried fruit intake on AD liability, this study utilized GWAS from the UK Biobank and FinnGen to conduct Mendelian randomization (MR) analysis, and used inverse variance weighted (IVW), MR-Egger, and weighted median approaches for MR estimates, and visual inspections judged result stability. Results suggested little evidence of a potential causal relationship between fresh fruit intake and AD (OR=0...
2024: Journal of Prevention of Alzheimer's Disease
https://read.qxmd.com/read/38374750/personalized-computational-causal-modeling-of-the-alzheimer-disease-biomarker-cascade
#11
JOURNAL ARTICLE
J R Petrella, J Jiang, E Sreeram, S Dalziel, P M Doraiswamy, W Hao
BACKGROUND: Mathematical models of complex diseases, such as Alzheimer's disease, have the potential to play a significant role in personalized medicine. Specifically, models can be personalized by fitting parameters with individual data for the purpose of discovering primary underlying disease drivers, predicting natural history, and assessing the effects of theoretical interventions. Previous work in causal/mechanistic modeling of Alzheimer's Disease progression has modeled the disease at the cellular level and on a short time scale, such as minutes to hours...
2024: Journal of Prevention of Alzheimer's Disease
https://read.qxmd.com/read/38374749/nanolithium-a-new-treatment-approach-to-alzheimer-s-disease-a-review-of-existing-evidence-and-clinical-perspectives
#12
REVIEW
S Guilliot, E N Wilson, J Touchon, M E Soto
Lithium has been approved and used for several decades in the treatment of psychiatric disorders, and its potential effect in neurodegenerative diseases has been subject to increasing research interest in recent years. Nanolithium is a new experimental product using a novel drug-delivery technology (Aonys®), which optimizes its bioavailability while reducing its toxicity profile. Therapeutic doses of lithium used in Nanolithium are more than 50 times lower than the minimal dose of classical lithium salts...
2024: Journal of Prevention of Alzheimer's Disease
https://read.qxmd.com/read/38374748/cytomegalovirus-infection-and-alzheimer-s-disease-a-meta-analysis
#13
JOURNAL ARTICLE
Q Ji, W Lian, Y Meng, W Liu, M Zhuang, N Zheng, I K Karlsson, Y Zhan
BACKGROUND: Evidence on the association of cytomegalovirus (CMV) infection with Alzheimer's disease (AD) is scarce and the results are inconsistent. OBJECTIVE: To investigate the association of CMV infection with the risk of AD. METHODS: Observational studies on the relationship between CMV infection and AD were identified from PubMed, Embase, Web of Science, and the Cochrane Library until September 30, 2022. The quality of included studies was assessed using the Newcastle-Ottawa Scale...
2024: Journal of Prevention of Alzheimer's Disease
https://read.qxmd.com/read/38374747/clinical-correlates-of-the-pet-based-braak-staging-framework-in-alzheimer-s-disease
#14
REVIEW
A C Macedo, D F P A Durço, C Tissot, J Therriault, A O Vilela de Faria, É Aumont, S Servaes, N Rahmouni, J Fernandez-Arias, Y-T Wang, F Z Lussier, A Bieger, E R Zimmer, T A Pascoal, S Gauthier, P Rosa-Neto
In vivo Alzheimer's disease diagnosis and staging is traditionally based on clinical features. However, the agreement between clinical and pathological Alzheimer's disease diagnosis, whose diagnosis assessment includes amyloid and Braak histopathological tau staging, is not completely convergent. The development of positron emission tomography (PET) tracers targeting neurofibrillary tangles offers prospects for advancing the staging of Alzheimer's disease from both biological and clinical perspectives. Recent advances in radiochemistry made it possible to apply the postmortem Braak staging framework to tau-PET images obtained in vivo...
2024: Journal of Prevention of Alzheimer's Disease
https://read.qxmd.com/read/38374746/cost-effectiveness-of-prevention-for-people-at-risk-for-dementia-a-scoping-review-and-qualitative-synthesis
#15
REVIEW
A Braun, M Höfler, S Auer
Dementia is from an economic perspective a main challenge for economies worldwide because of increasing costs. Since there is no cure in sight, prevention seems the most promising approach for reducing health care cost due to Dementia. On the contrary, approximately 40% of dementias is attributable to modifiable risk factors and first studies showed that multidomain interventions may be effective for preventing dementia. Considering the increasing economic burden, for many health administrations worldwide, cost-effectiveness plays a mayor role...
2024: Journal of Prevention of Alzheimer's Disease
https://read.qxmd.com/read/38374745/a-cholecystokinin-analogue-ameliorates-cognitive-deficits-and-regulates-mitochondrial-dynamics-via-the-ampk-drp1-pathway-in-app-ps1-mice
#16
JOURNAL ARTICLE
L Hao, M Shi, J Ma, S Shao, Y Yuan, J Liu, Z Yu, Z Zhang, C Hölscher, Z Zhang
BACKGROUND: There are no drugs on the market that can reverse or slow Alzheimer's disease (AD) progression. A protease-resistant Cholecystokinin (CCK) analogue used in this study is based on the basic structure of CCK, which further increases the stability of the peptide fragment and prolongs its half-life in vivo. We observed a neuroprotective effect of CCK-8L in APPswe/PS1dE9 (APP/PS1) AD mice. However, its corresponding mechanisms still need to be elucidated. OBJECTIVE: This study examined CCK-8L's neuroprotective effects in enhancing cognitive impairment by regulating mitochondrial dynamics through AMPK/Drp1 pathway in the APP/PS1 AD mice...
2024: Journal of Prevention of Alzheimer's Disease
https://read.qxmd.com/read/38374744/vortioxetine-treatment-for-depression-in-patients-with-prodromal-vs-mild-alzheimer-s-disease-a-six-month-open-label-observational-study
#17
JOURNAL ARTICLE
A Padovani, S Caratozzolo, A Benussi, A Galli, L Rozzini, M Cosseddu, R Turrone, A Pilotto
BACKGROUND: Depressive symptoms are common in Alzheimer disease (AD) from the prodromal stage. The benefits of antidepressants have been investigated in patients with AD dementia with mixed results. OBJECTIVES: This study aimed to compare the efficacy of vortioxetine in prodromal and mild-to-moderate AD patients with depression, and to assess the comparative effect on secondary measures, including behavioral disturbances, cognitive function, and activities of daily living...
2024: Journal of Prevention of Alzheimer's Disease
https://read.qxmd.com/read/38374743/a-phase-1-single-ascending-dose-trial-in-healthy-volunteers-to-evaluate-the-safety-tolerability-pharmacokinetics-and-immunogenicity-of-intravenous-pnt001-a-novel-mid-domain-tau-antibody-targeting-cis-pt231-tau
#18
JOURNAL ARTICLE
W Luca, K Foster, K McClure, M K Ahlijanian, M Jefson
BACKGROUND: PNT001 is a humanized full-length IgG4 S228P monoclonal antibody that binds the cis conformation of the phosphorylated Thr231-Pro232 motif in human full-length (2N4R) tau (cis-pT231 tau) with high selectivity and affinity. It binds selectively to cis-pT231 tau in human tauopathy brain sections, inhibits aggregation of tau, and has shown efficacy in preclinical models of tauopathy. Good Laboratory Practice six-month toxicology studies in cynomolgous monkeys have shown no test article-related findings...
2024: Journal of Prevention of Alzheimer's Disease
https://read.qxmd.com/read/38374742/roles-of-baseline-intrinsic-capacity-and-its-subdomains-on-the-overall-efficacy-of-multidomain-intervention-in-promoting-healthy-aging-among-community-dwelling-older-adults-analysis-from-a-nationwide-cluster-randomized-controlled-trial
#19
JOURNAL ARTICLE
C-K Liang, W-J Lee, M-Y Chou, A-C Hwang, C-S Lin, L-N Peng, F-Y Hsiao, C-H Loh, L-K Chen
BACKGROUND: Impaired intrinsic capacity (IC), which affects approximately 90% of older adults, is associated with a significantly heightened risk of frailty and cognitive decline. Existing evidence suggests that multidomain interventions have the potential to enhance cognitive performance and yield positive effects on physical frailty. OBJECTIVE: To examine roles of baseline IC and its subdomains on the efficacy of multidomain interventions in promoting healthy aging in older adults...
2024: Journal of Prevention of Alzheimer's Disease
https://read.qxmd.com/read/38374741/who-benefited-the-most-effectiveness-of-a-lifestyle-intervention-against-cognitive-decline-in-older-women-and-men-secondary-analysis-of-the-agewell-de-trial
#20
RANDOMIZED CONTROLLED TRIAL
F G Wittmann, A Pabst, A Zülke, M Luppa, I Blotenberg, M I Cardona, A Bauer, S Fuchs, I Zöllinger, L Sanftenberg, C Brettschneider, J Döhring, L Lunden, D Czock, B Wiese, J R Thyrian, W Hoffmann, T Frese, J Gensichen, H-H König, H Kaduszkiewicz, S G Riedel-Heller
INTRODUCTION: Differences between women and men matter in the prevalence and risk factors of dementia. We aimed to examine potential sex differences regarding the effectiveness by running a secondary analysis of the AgeWell.de trial, a cluster-randomized multicenter multi-domain lifestyle intervention to reduce cognitive decline. METHODS: Intention-to-treat analyses of women (n=433) and men (n=386) aged 60 to 77 years were used for models including interactions between intervention group allocation and sex followed by subgroup analysis stratified by sex on primary and secondary outcomes...
2024: Journal of Prevention of Alzheimer's Disease
journal
journal
48972
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.